Oseltamivir prescription and regulatory actions vis-à-vis abnormal behavior risk in Japan: drug utilization study using a nationwide pharmacy database.

Oseltamivir prescription and regulatory actions vis-à-vis abnormal behavior risk in Japan: drug utilization study using a nationwide pharmacy database.

BACKGROUND: In March 2007, a regulatory advisory was issued in Japan to restrict oseltamivir use in children aged 10-19 years because of safety concerns over abnormal behavior. The effectiveness and validity of regulatory risk minimization actions remain to be reviewed, despite their significant pub...

Full description

Bibliographic Details
Main Authors: Hisashi Urushihara, Yuko Doi, Masaru Arai, Toshiyuki Matsunaga, Yosuke Fujii, Naoko Iino, Takashi Kawamura, Koji Kawakami
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3232227?pdf=render

Internet

http://europepmc.org/articles/PMC3232227?pdf=render

Similar Items